{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [],
  "article_type": null,
  "arxiv": null,
  "author_total": 8,
  "authors": [
    {
      "name": "Róża K. Przanowska"
    },
    {
      "name": "Jacky Gomez-Villa"
    },
    {
      "name": "Victoria J. Liu"
    },
    {
      "name": "Natalia Antonides-Jensen"
    },
    {
      "name": "Lavanya Visvabharathy"
    },
    {
      "name": "John C. Alverdy"
    },
    {
      "name": "Sonia L. Hernandez"
    },
    {
      "name": "Samantha S. Yee",
      "orcid": "0000-0001-7953-0183"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/273wkd2xdekmq.bib",
  "cited_by": 0,
  "doi": "10.1038/s41598-026-75881-7",
  "fulltext_url": null,
  "id": "273wkd2xdekmq",
  "issns": [
    "2045-2322"
  ],
  "landing_url": "https://www.nature.com/articles/s41598-026-75881-7",
  "language": null,
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2730|Cytokine Signaling Pathways and Interactions"
    ]
  ],
  "openalex": "W7222535341",
  "pdf_url": "https://www.nature.com/articles/s41598-026-75881-7_reference.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-16",
  "publisher": "Springer Science and Business Media LLC",
  "ris": "https://research.draconitic.com/paper/273wkd2xdekmq.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:28Z",
      "native_id": "10.1038/s41598-026-75881-7",
      "source": "crossref",
      "url": "https://www.nature.com/articles/s41598-026-75881-7"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cytokine Signaling Pathways and Interactions",
      "subfield": "oncology"
    }
  ],
  "title": "IL-6R blockade with tocilizumab disrupts pericyte– and tumor cell–driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer",
  "title_text": "IL-6R blockade with tocilizumab disrupts pericyte– and tumor cell–driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:17:28Z",
  "url": "https://research.draconitic.com/paper/273wkd2xdekmq",
  "venue": "Scientific Reports",
  "versions": []
}